HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...

Lenacapavir is an antiretroviral medicine that helps prevent 99.9 per cent of all HIV transmission, according to studies.

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...

The U.S. Food and Drug Administration has approved a new HIV prevention medication that's been found to be highly effective.

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

The breakthrough double injection won’t be cheap in the US, although scientists argue it could (and should) be.

Juanita Davis with Care4Me services has been educating people in the metro area about HIV prevention and she hopes the drug’s ...

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

The United States Food and Drug Administration, FDA, has approved a new long-acting injectable drug, Lenacapavir, for the ...

The United States Food and Drug Administration (FDA) has approved a twice-a-year drug to be used to prevent HIV.

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

Colombian billionaire Jaime Gilinski Bacal is open to selling his majority stake in British lender Metro Bank and has ...